(ABL) Abacus Life - Ratings and Ratios

Abacus Life Inc. (NASDAQ:ABL) is a multifaceted alternative asset manager and market maker in the United States, operating through a diversified structure comprising Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. The company is intricately involved in the life insurance secondary market, facilitating transactions between policyholders and investors, and providing a range of ancillary services including policy servicing and asset management. Abacus Life Inc. leverages various distribution channels, including financial advisors, direct-to-consumer sales, and traditional life settlements intermediaries, to market its products. The companys comprehensive suite of services is tailored to meet the complex needs of the life insurance market, including real-time mortality verification and missing participant verification.

From a business perspective, Abacus Life Inc. has positioned itself as a versatile player in the life insurance and alternative asset management sectors. The companys diversified business model, spanning policy trading, origination, and servicing, as well as technology services, provides a robust foundation for revenue generation. With a presence in the United States and a foundation established in 2004, Abacus Life has evolved to become a significant entity in the life settlements industry. The recent name change to Abacus Global Management, Inc. (effective February 2025) may signal an expansion or reorientation of the companys global ambitions or operational scope.

Analyzing the available and , Abacus Life Inc. (ABL) is currently trading at $5.44, with its 20-day, 50-day, and 200-day moving averages at $6.16, $7.49, and $8.07, respectively. The stocks price is below these averages, indicating a downtrend. The Average True Range (ATR) of 0.43 represents a 7.84% fluctuation, suggesting volatility. The stocks 52-week high and low are $10.98 and $5.31, respectively, further highlighting the recent downturn. The companys market capitalization stands at $522.14M USD, with a forward P/E of 10.57 and a negative Return on Equity (RoE) of -5.23, indicating potential earnings challenges.

Based on the available data, a forecast for Abacus Life Inc. could be as follows: Given the current downtrend and the stocks volatility, as indicated by the ATR, the price may continue to fluctuate. However, if the company can address its earnings challenges and improve its RoE, the stock could see a rebound. A potential target could be the 52-week high of $10.98, representing a significant upside. Conversely, failure to address underlying issues could lead to further decline, potentially towards the 52-week low of $5.31. A break above the 20-day SMA of $6.16 could be a positive signal, indicating a potential shift in the trend. Conversely, a failure to sustain above this level could indicate ongoing weakness.